89 related articles for article (PubMed ID: 12962743)
1. Importance of tumoral markers in donors: study of prostate-specific antigen.
González-Segura C; Pascual M; Cañizares R; García-Huete L; Torras J; Riera L; Condom E
Transplant Proc; 2003 Aug; 35(5):1647-9. PubMed ID: 12962743
[TBL] [Abstract][Full Text] [Related]
2. Prostate-Specific Antigen: Nonspecific in Deceased Organ Donors.
Pabisiak K; Ostrowski M; Kram A; Safranow K; Myślak M; Sieńko J; Sulikowski T; Ciechanowski K
Transplant Proc; 2016 Jun; 48(5):1374-7. PubMed ID: 27496408
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen in the assessment of organ donors.
Frutos MA; Daga D; Ruiz P; Jose Mansilla J; Requena MV
Transplant Proc; 2003 Aug; 35(5):1644-6. PubMed ID: 12962742
[TBL] [Abstract][Full Text] [Related]
4. Prostate Specific Antigen-Positive Deceased Organ Donor: A Pathologist Is Indispensable.
Pabisiak K; Ostrowski M; Kram A; Safranow K; Słojewski M; Ciechanowski K
Transplant Proc; 2016 Sep; 48(7):2450-2453. PubMed ID: 27742319
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
Zagars GK
J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
Zagars GK; Pollack A; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
[TBL] [Abstract][Full Text] [Related]
7. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
8. The patients less than 50 years: is there a need to lower the PSA cutoff point?
Hekal IA
Prostate Cancer Prostatic Dis; 2009; 12(2):148-51. PubMed ID: 18825164
[TBL] [Abstract][Full Text] [Related]
9. Prostate adenocarcinoma using Gleason scores correlates with prostate-specific antigen and prostate acid phosphatase measurements.
Shih WJ; Gross K; Mitchell B; Collins J; Wierzbinski B; Magoun S; Ryo UY
J Natl Med Assoc; 1992 Dec; 84(12):1049-50. PubMed ID: 1284282
[TBL] [Abstract][Full Text] [Related]
10. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
11. Role of Ca 15-3 in patients with biochemically suspected prostate cancer and multiple negative ultrasound-guided prostate biopsies.
Falsaperla M; Morgia G; Giammusso B; Condorelli SV; Saita A; Marchese F; Spampinato A; Motta M
Prostate Cancer Prostatic Dis; 2003; 6(1):45-9. PubMed ID: 12664064
[TBL] [Abstract][Full Text] [Related]
12. [Significance of the PSA-concentration for the detection of prostate cancer].
Stachon A
Pathologe; 2005 Nov; 26(6):469-72. PubMed ID: 16195861
[TBL] [Abstract][Full Text] [Related]
13. Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men.
Sjoberg DD; Vickers AJ; Assel M; Dahlin A; Poon BY; Ulmert D; Lilja H
Eur Urol; 2018 Jun; 73(6):941-948. PubMed ID: 29519548
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Peripheral Vein Tumour Marker Levels, Internal Iliac Vein Tumour Marker Levels and Radical Prostatectomy Specimens in Patients with Prostate Cancer and Borderline High Prostate-Specific Antigen: A Pilot Study.
Farrelly C; Lal P; Trerotola SO; Nadolski GJ; Watts MM; Gorrian CM; Guzzo TJ
Cardiovasc Intervent Radiol; 2016 May; 39(5):724-731. PubMed ID: 26957011
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
Soga N; Onishi T; Arima K; Sugimura Y
Int J Urol; 2007 Mar; 14(3):192-6; discussion 197. PubMed ID: 17430253
[TBL] [Abstract][Full Text] [Related]
16. Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy.
Janbaziroudsari H; Mirzaei A; Maleki N
Bull Cancer; 2016 Sep; 103(9):730-4. PubMed ID: 27345449
[TBL] [Abstract][Full Text] [Related]
17. Serum prostate-specific antigen and prostate pathology in men having simple prostatectomy.
Brawer MK; Rennels MA; Nagle RB; Schifman R; Gaines JA
Am J Clin Pathol; 1989 Dec; 92(6):760-4. PubMed ID: 2480060
[TBL] [Abstract][Full Text] [Related]
18. [Comparison in the follow-up of two patients with persistent elevated PSA and negative prostate biopsy].
Sciarra A; Panebianco V
Urologia; 2014; 81(1):60-3. PubMed ID: 24585440
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the pathologic results of prostate biopsies in terms of age, Gleason score and PSA level: our experience and review of the literature.
Sarıkaya S; Resorlu M; Oguz U; Yordam M; Bozkurt OF; Unsal A
Arch Ital Urol Androl; 2014 Dec; 86(4):288-90. PubMed ID: 25641453
[TBL] [Abstract][Full Text] [Related]
20. Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?
Raviv G; Zlotta AR; Janssen Th; Descamps F; Vanegas JP; Verhest A; Schulman CC
Cancer; 1996 May; 77(10):2103-8. PubMed ID: 8640677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
